Free Trial

CARGO Therapeutics (CRGX) Competitors

CARGO Therapeutics logo
$14.90 +1.39 (+10.29%)
(As of 12/20/2024 05:40 PM ET)

CRGX vs. HCM, CPRX, AGIO, PTGX, IOVA, AMRX, LBPH, NAMS, IDYA, and CNTA

Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include HUTCHMED (HCM), Catalyst Pharmaceuticals (CPRX), Agios Pharmaceuticals (AGIO), Protagonist Therapeutics (PTGX), Iovance Biotherapeutics (IOVA), Amneal Pharmaceuticals (AMRX), Longboard Pharmaceuticals (LBPH), NewAmsterdam Pharma (NAMS), IDEAYA Biosciences (IDYA), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "pharmaceutical products" industry.

CARGO Therapeutics vs.

HUTCHMED (NASDAQ:HCM) and CARGO Therapeutics (NASDAQ:CRGX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation.

HUTCHMED currently has a consensus price target of $19.00, suggesting a potential upside of 32.77%. CARGO Therapeutics has a consensus price target of $31.80, suggesting a potential upside of 113.42%. Given CARGO Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CARGO Therapeutics is more favorable than HUTCHMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HUTCHMED
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
CARGO Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

HUTCHMED's return on equity of 0.00% beat CARGO Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
HUTCHMEDN/A N/A N/A
CARGO Therapeutics N/A -38.16%-33.94%

HUTCHMED received 301 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 66.32% of users gave HUTCHMED an outperform vote.

CompanyUnderperformOutperform
HUTCHMEDOutperform Votes
315
66.32%
Underperform Votes
160
33.68%
CARGO TherapeuticsOutperform Votes
14
100.00%
Underperform Votes
No Votes

HUTCHMED has higher revenue and earnings than CARGO Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HUTCHMED$420.26M5.94$100.78MN/AN/A
CARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.50

8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 3.6% of HUTCHMED shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, CARGO Therapeutics had 3 more articles in the media than HUTCHMED. MarketBeat recorded 4 mentions for CARGO Therapeutics and 1 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 1.05 beat CARGO Therapeutics' score of 0.39 indicating that HUTCHMED is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HUTCHMED
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CARGO Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

HUTCHMED beats CARGO Therapeutics on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRGX vs. The Competition

MetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$685.82M$2.94B$5.12B$9.07B
Dividend YieldN/A1.90%4.91%4.22%
P/E Ratio-3.5046.7391.3417.19
Price / SalesN/A411.851,116.59116.80
Price / CashN/A182.1042.6437.86
Price / Book1.513.894.794.78
Net Income-$98.15M-$42.21M$120.07M$225.60M
7 Day Performance8.44%-2.14%-1.89%-1.24%
1 Month Performance-5.28%4.21%11.45%3.36%
1 Year Performance-25.43%18.40%30.61%16.58%

CARGO Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRGX
CARGO Therapeutics
1.4673 of 5 stars
$14.90
+10.3%
$31.80
+113.4%
-20.0%$685.82MN/A-3.50116High Trading Volume
HCM
HUTCHMED
2.5943 of 5 stars
$14.94
-4.1%
$19.00
+27.2%
-15.0%$2.60B$838M0.001,988Positive News
CPRX
Catalyst Pharmaceuticals
4.6873 of 5 stars
$21.78
+1.9%
$31.14
+43.0%
+48.7%$2.60B$398.20M18.12167
AGIO
Agios Pharmaceuticals
4.2912 of 5 stars
$44.19
+13.4%
$56.33
+27.5%
+53.6%$2.52B$32.87M3.73390Analyst Forecast
PTGX
Protagonist Therapeutics
3.582 of 5 stars
$41.45
+0.9%
$53.78
+29.7%
+100.0%$2.47B$60M15.44125News Coverage
Positive News
IOVA
Iovance Biotherapeutics
4.005 of 5 stars
$7.90
+0.9%
$22.33
+182.7%
+2.8%$2.41B$1.19M-5.25500
AMRX
Amneal Pharmaceuticals
2.8869 of 5 stars
$7.75
-1.0%
$10.00
+29.0%
+47.1%$2.40B$2.68B-11.387,700Analyst Downgrade
News Coverage
Positive News
LBPH
Longboard Pharmaceuticals
0.6607 of 5 stars
$59.98
+0.0%
$59.56
-0.7%
+986.6%$2.34BN/A-26.9020
NAMS
NewAmsterdam Pharma
2.8425 of 5 stars
$24.50
-0.8%
$36.20
+47.8%
+142.4%$2.26B$33.59M0.0057Insider Trade
Analyst Revision
Gap Down
IDYA
IDEAYA Biosciences
4.3209 of 5 stars
$25.95
+3.0%
$53.67
+106.8%
-23.7%$2.24B$3.92M-10.8180Analyst Forecast
CNTA
Centessa Pharmaceuticals
3.0004 of 5 stars
$16.38
-1.1%
$25.83
+57.7%
+131.0%$2.16B$6.85M-10.8372Insider Trade

Related Companies and Tools


This page (NASDAQ:CRGX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners